Literature DB >> 15123060

The use of mathematical models to evaluate pelvic masses; can they beat an expert operator?

Dirk Timmerman1.   

Abstract

The pre-operative characterization of ovarian cysts remains a major challenge. Functional cysts and some other benign cysts should be managed conservatively, whereas persistent tumours may need removal. It is crucial to distinguish between malignant tumours, which are better treated by a gynaecological oncologist, and benign tumours, which may be suitable for minimal-access surgery. Over the past decade several ultrasound-based morphological scoring systems, colour Doppler parameters, logistic regression models and artificial neural networks have been proposed and tested in order to try to predict the histology of ovarian tumours. On prospective testing none of the current models can beat an expert sonologist. Signs of malignancy include the presence of papillary structures, irregular solid areas, septa and a strong vascularization at colour Doppler imaging. Further refinement of mathematical models and the results of multicentre trials need to be reviewed before the clinical use of mathematical models can be advocated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123060     DOI: 10.1016/j.bpobgyn.2003.09.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  13 in total

Review 1.  Ovarian cancer screening.

Authors:  Usha Menon
Journal:  CMAJ       Date:  2004-08-17       Impact factor: 8.262

2.  Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.

Authors:  Dirk Timmerman; Lieveke Ameye; Daniela Fischerova; Elisabeth Epstein; Gian Benedetto Melis; Stefano Guerriero; Caroline Van Holsbeke; Luca Savelli; Robert Fruscio; Andrea Alberto Lissoni; Antonia Carla Testa; Joan Veldman; Ignace Vergote; Sabine Van Huffel; Tom Bourne; Lil Valentin
Journal:  BMJ       Date:  2010-12-14

3.  Imaging in gynaecology: How good are we in identifying endometriomas?

Authors:  C Van Holsbeke; B Van Calster; S Guerriero; L Savelli; F Leone; D Fischerova; A Czekierdowski; R Fruscio; J Veldman; G Van de Putte; A C Testa; T Bourne; L Valentin; D Timmerman
Journal:  Facts Views Vis Obgyn       Date:  2009

Review 4.  The characteristic ultrasound features of specific types of ovarian pathology (review).

Authors:  Ahmad Sayasneh; Christine Ekechi; Laura Ferrara; Jeroen Kaijser; Catriona Stalder; Shyamaly Sur; Dirk Timmerman; Tom Bourne
Journal:  Int J Oncol       Date:  2014-11-18       Impact factor: 5.650

5.  Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population.

Authors:  Wouter Froyman; Laure Wynants; Chiara Landolfo; Tom Bourne; Lil Valentin; Antonia Testa; Povilas Sladkevicius; Dorella Franchi; Daniela Fischerova; Luca Savelli; Ben Van Calster; Dirk Timmerman
Journal:  Diagnostics (Basel)       Date:  2017-06-02

6.  Validation of IOTA-ADNEX Model in Discriminating Characteristics of Adnexal Masses: A Comparison with Subjective Assessment.

Authors:  Soo Young Jeong; Byung Kwan Park; Yoo Young Lee; Tae-Joong Kim
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

Review 7.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

8.  Multicentre external validation of IOTA prediction models and RMI by operators with varied training.

Authors:  A Sayasneh; L Wynants; J Preisler; J Kaijser; S Johnson; C Stalder; R Husicka; Y Abdallah; F Raslan; A Drought; A A Smith; S Ghaem-Maghami; E Epstein; B Van Calster; D Timmerman; T Bourne
Journal:  Br J Cancer       Date:  2013-05-14       Impact factor: 7.640

9.  Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  A Sharma; M Burnell; A Gentry-Maharaj; S Campbell; N N Amso; M W Seif; G Fletcher; C Brunell; G Turner; R Rangar; A Ryan; I Jacobs; U Menon
Journal:  Ultrasound Obstet Gynecol       Date:  2016-02       Impact factor: 7.299

10.  Reliability of preoperative evaluation of postmenopausal ovarian tumors.

Authors:  Riikka Johanna Niemi; Sami Kristian Saarelainen; Tiina Hannele Luukkaala; Johanna Unelma Mäenpää
Journal:  J Ovarian Res       Date:  2017-03-14       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.